CHEMED CORP
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
CHE$538.06+1.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| CONSOLIDATED BALANCE SHEETS | ||
|---|---|---|
| Chemed Corporation and Subsidiary Companies | ||
| (in thousands, except shares and per share data) | ||
| December 31, | 2025 | 2024 |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents (Note 9) | $74,515 | $178,350 |
| Accounts receivable | 182,575 | 171,163 |
| Inventories | 7,543 | 8,193 |
| Prepaid income taxes | 11,165 | 11,068 |
| Prepaid expenses | 26,818 | 25,974 |
| Total current assets | 302,616 | 394,748 |
| Investments of deferred compensation plans held in trust (Notes 15 and 17) | 140,347 | 130,960 |
| Properties and equipment, at cost, less accumulated depreciation (Note 13) | 205,662 | 200,837 |
| Lease right of use asset (Note 14) | 131,151 | 127,323 |
| Identifiable intangible assets less accumulated amortization (Note 6) | 82,764 | 92,206 |
| Goodwill | 666,999 | 666,744 |
| Other assets (Note 12) | 8,650 | 55,757 |
| Total Assets | $1,538,189 | $1,668,575 |
| Liabilities | ||
| Current liabilities | ||
| Accounts payable | $64,459 | $44,146 |
| Accrued insurance | 62,054 | 56,703 |
| Income taxes (Note 11) | 2,504 | 7,593 |
| Accrued compensation | 58,329 | 92,073 |
| Short-term lease liability (Note 14) | 40,892 | 42,306 |
| Other current liabilities (Note 21) | 58,892 | 42,874 |
| Total current liabilities | 287,130 | 285,695 |
| Deferred income taxes (Note 11) | 19,313 | 25,945 |
| Deferred compensation liabilities (Note 15) | 136,139 | 126,035 |
| Long-term lease liability (Note 14) | 102,867 | 98,538 |
| Other liabilities | 13,335 | 13,369 |
| Total Liabilities | 558,784 | 549,582 |
| Commitments and contingencies (Note 18) | ||
| Stockholders' Equity | ||
| Capital stock - authorized 80,000,000 shares $1 par; issued 37,594,676 shares | ||
| (2024 - 37,422,348 shares) | 37,595 | 37,422 |
| Paid-in capital | 1,592,197 | 1,484,176 |
| Retained earnings | 2,955,375 | 2,721,832 |
| Treasury stock - 23,884,187 shares (2024 - 22,865,842 shares), at cost | (3,608,117) | (3,126,660) |
| Deferred compensation payable in Company stock (Note 15) | 2,355 | 2,223 |
| Total Stockholders' Equity | 979,405 | 1,118,993 |
| Total Liabilities and Stockholders' Equity | $1,538,189 | $1,668,575 |
| The Notes to Consolidated Financial Statements are integral parts of these statements. | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.